MAIA Biotechnology, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

Subsequent Events - Additional Information - (Details)

Subsequent Events - Additional Information - (Details) - USD ($)										3 Months Ended	12 Months Ended
	Mar. 03, 2025	Feb. 25, 2025	Feb. 24, 2025	Dec. 13, 2024	Nov. 01, 2024	Apr. 25, 2024	Apr. 22, 2024	Mar. 28, 2024	Mar. 14, 2024	Mar. 21, 2025	Dec. 31, 2024	Aug. 01, 2022
Subsequent Event [Line Items]
Options outstanding, Granted											3,043,874
Weighted average Exercise Price, Exercised											$ 1.81
Warrants exercise price, per share												$ 6.25
Private Placement
Subsequent Event [Line Items]
Common stock per share				$ 1.872	$ 2.259		$ 2.034	$ 2.295	$ 1.17
Aggregate purchase price				$ 950,000	$ 2,440,000		$ 1,000,000	$ 1,330,000	$ 2,920,000
Warrants exercise price, per share									$ 1.3
Stan Smith \| Private Placement
Subsequent Event [Line Items]
Number of common stock Issued and sold				25,000	100,000	147,492					170,940
Warrants to purchase common stock				25,000	100,000	147,492					170,940
Aggregate purchase price				$ 46,800	$ 225,900	$ 300,000					$ 200,000
Ramiro Guerrero \| Private Placement
Subsequent Event [Line Items]
Number of common stock Issued and sold				54,518	88,534						6,928
Warrants to purchase common stock				53,418	88,534						6,928
Aggregate purchase price				$ 100,000	$ 200,000						$ 8,106
Common Stock \| Private Placement
Subsequent Event [Line Items]
Number of common stock Issued and sold				507,364	1,079,784	494,096		578,643	2,496,318
Investor Warrants \| Private Placement
Subsequent Event [Line Items]
Number of common stock Issued and sold				507,364	1,079,784	494,096		578,643	2,496,318
Common stock per share				$ 2.08	$ 2.51	$ 2.26		$ 2.55	$ 1.3
Subsequent Event
Subsequent Event [Line Items]
Options outstanding, Granted										456,545
Weighted average Exercise Price, Exercised										$ 1.41
Subsequent Event \| At The Market Offering Agreement \| H.C. Wainwright and Co., LLC
Subsequent Event [Line Items]
Number of common stock Issued and sold										666,323
Common stock per share										$ 2.28
Gross proceeds from sale of common stock										$ 1,521,092
Net proceeds from common stock										1,475,458
Commissions paid										$ 45,633
Subsequent Event \| Private Placement
Subsequent Event [Line Items]
Common stock per share	$ 1.5		$ 1.5
Aggregate purchase price	$ 1,430,000		$ 2,720,000
Subsequent Event \| Stan Smith \| Private Placement
Subsequent Event [Line Items]
Number of common stock Issued and sold	25,000	50,000
Warrants to purchase common stock	25,000	50,000
Aggregate purchase price	$ 37,500	$ 75,000
Subsequent Event \| Ramiro Guerrero \| Private Placement
Subsequent Event [Line Items]
Number of common stock Issued and sold	33,333	73,333
Warrants to purchase common stock	33,333	73,333
Aggregate purchase price	$ 50,000	$ 110,000
Subsequent Event \| FGMK Business Holdings, LLC \| Private Placement
Subsequent Event [Line Items]
Number of common stock Issued and sold		1,350,000
Warrants to purchase common stock		1,350,000
Aggregate purchase price		$ 2,025,000.000
Stockholder purchased		5.00%
Subsequent Event \| Common Stock \| Private Placement
Subsequent Event [Line Items]
Number of common stock Issued and sold	952,633		1,810,000
Subsequent Event \| Warrants \| Private Placement
Subsequent Event [Line Items]
Number of common stock Issued and sold	952,633		1,810,000
Subsequent Event \| Investor Warrants \| Private Placement
Subsequent Event [Line Items]
Warrants exercise price, per share	$ 1.85		$ 1.87